MapLight Therapeutics
$7.58
5
-$0.14-1.81%Friday 20:00
Statistics
Day High
7.6
Day Low
7.54
52W High
40.43
52W Low
7.44
Volume
21,047
Avg. Volume
-
Mkt Cap
421.26M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 3Expected
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-37.18
-25.14
-13.09
-1.05
Expected EPS
-1.195615
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-161.15MNet Income
Analyst Ratings
$33.88Average Price Target
The highest estimate is 46.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
Show More
CEO
Christopher A. Kroeger
Employees
133
Country
United States
ISIN
US56565P1030
Listings
0 Comments
Share your thoughts
FAQs
What is MapLight Therapeutics stock price today?▼
The current price of MPLT is $7.58 USD — it has decreased by -1.81% in the past 24 hours. Watch MapLight Therapeutics stock price performance more closely on the chart.
What is MapLight Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange MapLight Therapeutics stocks are traded under the ticker MPLT.
Is MapLight Therapeutics stock price growing?▼
MPLT stock has fallen by -4.89% compared to the previous week, the month change is a -21.29% fall, over the last year MapLight Therapeutics has showed a -55.2% decrease.
What is MapLight Therapeutics market cap?▼
Today MapLight Therapeutics has the market capitalization of 421.26M
When is the next MapLight Therapeutics earnings date?▼
MapLight Therapeutics is going to release the next earnings report on December 3, 2026.
What were MapLight Therapeutics earnings last quarter?▼
MPLT earnings for the last quarter are -1.32 USD per share, whereas the estimation was -1.35 USD resulting in a +2.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MapLight Therapeutics revenue for the last year?▼
MapLight Therapeutics revenue for the last year amounts to 0 USD.
What is MapLight Therapeutics net income for the last year?▼
MPLT net income for the last year is -161.15M USD.
How many employees does MapLight Therapeutics have?▼
As of November 1, 2026, the company has 133 employees.
In which sector is MapLight Therapeutics located?▼
MapLight Therapeutics operates in the Health & Wellness sector.
When did MapLight Therapeutics complete a stock split?▼
MapLight Therapeutics has not had any recent stock splits.
Where is MapLight Therapeutics headquartered?▼
MapLight Therapeutics is headquartered in REDWOOD CITY, United States.